View in EDS HTML Full Text PDF Full Text

Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.

Saved in:
Bibliographic Details
Title: Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
Authors: Krishnan M; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA. mridula.krishnan@unmc.edu., Bociek RG; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Fanale M; Department of Lymphoma/Multiple Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Iyer SP; Department of Lymphoma/Multiple Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Lechowicz MJ; Department of Hematology, Emory University, Atlanta, GA, USA., Bierman PJ; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Armitage JO; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Lunning M; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Kallam A; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Vose JM; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Source: Annals of hematology [Ann Hematol] 2022 Feb; Vol. 101 (2), pp. 335-340. Date of Electronic Publication: 2021 Oct 20.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34668982
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Krishnan+M%22">Krishnan M</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA. mridula.krishnan@unmc.edu.<br /><searchLink fieldCode="AU" term="%22Bociek+RG%22">Bociek RG</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Fanale+M%22">Fanale M</searchLink>; Department of Lymphoma/Multiple Myeloma, MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Iyer+SP%22">Iyer SP</searchLink>; Department of Lymphoma/Multiple Myeloma, MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lechowicz+MJ%22">Lechowicz MJ</searchLink>; Department of Hematology, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Bierman+PJ%22">Bierman PJ</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Armitage+JO%22">Armitage JO</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Lunning+M%22">Lunning M</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Kallam+A%22">Kallam A</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Vose+JM%22">Vose JM</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2022 Feb; Vol. 101 (2), pp. 335-340. <i>Date of Electronic Publication: </i>2021 Oct 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34668982
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-021-04692-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 335
    Titles:
      – TitleFull: Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Krishnan M
      – PersonEntity:
          Name:
            NameFull: Bociek RG
      – PersonEntity:
          Name:
            NameFull: Fanale M
      – PersonEntity:
          Name:
            NameFull: Iyer SP
      – PersonEntity:
          Name:
            NameFull: Lechowicz MJ
      – PersonEntity:
          Name:
            NameFull: Bierman PJ
      – PersonEntity:
          Name:
            NameFull: Armitage JO
      – PersonEntity:
          Name:
            NameFull: Lunning M
      – PersonEntity:
          Name:
            NameFull: Kallam A
      – PersonEntity:
          Name:
            NameFull: Vose JM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2022 Feb
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0584
          Numbering:
            – Type: volume
              Value: 101
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1